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The newly developed XE-2100 haematology analyser can
provide complete blood counts, leukocyte differentials, perform
reticulocyte analysis, and obtain quantitative data on nucleated
red blood cells (NRBCs). In this study, we evaluated the basic
performance of this instrument using routinely obtained blood
specimens treated with ethylenediaminetetraacetic acid-2If.
Reproducibility, carryover, stability during storage at 4C
and room temperature, and accuracy were evaluated. In this
evaluation, reproducibility was good and little carryover was
found. Accurate measurements were possible for up to 48h
of storage. A good correlation between findings with the
XE-2100 and SE-9000 haematology analysers was found for
complete blood count on 210 samples tested. The leukocyte
differential obtained with the XE-2100 correlated well with eye
counts and with the results obtained with the SE-9000 automated
haematology analyser, with r values over 0.9 for the percentages
of neutrophils, lymphocytes and eosinophils. The precision and
accuracy of VRBC and reticulocyte counts by the XE-2100
were satisfactory. We used the XE-2100 to obtain differential
counts for bone marrow aspirates, and good correlations with
manual differentials were obtained for total nucleated cell count,
percentage of myeloid cells and percentage of erythroid cells.
The performance of the XE-2100 was excellent, and this
instrument should be able to provide reliable data to clinical
laboratories.
Introduction
New haematology analysers have recently been
developed, and each has been claimed to improve
laboratory efficiency by increasing automation capabil-
ities or by the addition of new parameters that could
not previously be automatically determined. The
XE-2100 haematology analyser (Sysmex, Kobe,
Japan) was developed to meet the needs of present
and future clinical laboratories. It can provide maximal
information to haematology laboratories, including
simultaneous complete blood counts, leukocyte
differential counts, and reticulocyte analytes. It is
capable of determining a new parameter, the count
of nucleated red blood cells (NRBCs), not obtainable
with previous Sysmex instruments. Its high throughput
will have a beneficial impact especially on large-sized
laboratories required to analyse increasing numbers
of specimens. In this study, we performed a basic
evaluation of the XE-2100.
Materials and methods
Materials
Venous blood treated with ethylenediaminetetraacetic
acid-2K was processed within 6 h after blood collection,
except for stability tests. The samples were selected from
the laboratory routine workload except when otherwise
indicated.
Determination ofparameters by the XE-2100
The principle of determination of the complete blood
count is the same as that used by the Sysmex SF-3000, a
blood cell counter with semi-conductor laser light [1]
performing haemoglobinometry based on the sodium
lauryl sulphate method to avoid hazardous cyanide
waste. The immature cell information channel already
used in the SE-9000 is also installed in the XE-2100.
Leukocyte differential, enumeration of NRBCs and re-
ticulocyte analysis are performed using new reagents, and
cellular characteristics are detected by semi-conductor
laser. Details of the new principle of determination used
by the XE-2100 are not yet available due to an ongoing
patent application, but the limited information we were
able to obtain is as follows.
Leukocytes are suspended in a lysing reagent in the
instrument, the leukocyte membrane is slightly damaged,
and then the cells are stained with the new reagent
’4DIFF’, which contains a dye that binds to DNA and
RNA. On a scattergram, neutrophils, lymphocytes,
monocytes and eosinophils are visualized as distinctive
clusters on the axes of fluorescence intensity and internal
structures of cells treated with the reagent (figure 1, left
top). Basophils are detected separately from other leuko-
cytes (figure 1, right top) using a pH3 reagent, e.g.
SF-3000 [1]. In order to detect NRBC, the cells are
first lysed with a pH3 reagent with a low osmotic pressure
of 50mOsmol/1, and then stained with ’NRBC’ reagent
containing another DNA-binding dye to detect NRBCs.
Erythrocyte ghosts have no fluorescence and are smaller
than NRBCs, and leukocytes have higher fluorescence
than NRBCs. On scattergrams of fluorescence and size,
NRBCs are distributed in the central area, between
erythrocyte ghosts and leukocytes (figure 1, right
middle). The number of NRBCs per 100 leuykocytes is
shown as ’NRBC/o on reports. Reticulocyte analysis is
performed using the new reagent ’RETII’, which con-
tains a dye that binds RNA and DNA. Reticulocytes and
mature erythrocytes can be differentiated by fluorescence
intensity (figure 1, right bottom). Platelets are distributed
on the bottom left of this scattergram due to their small
size and low fluorescence, and the count obtained here is
used as an optical platelet count (PLT-O). The reticu-
locyte distribution area is divided into three regions,
Journal ofAutomated Methods & Management its Chemistry ISSN 1463-9246 print/ISSN 1464-5068 online (C) 1999 Taylor & Francis Ltd
http:llwww.tandf.co.uk]JNLSlauc.htm
http:llwww.taylorandfrancis.com/JNLSlauc.htm
127I. Tsuda et al. XE-2100 haematology analyser
Diff
"...
Men Ly
o Neu
Side scatter
WBC/Bas
Bas
Side scatter
IMI
= eft Shift
e Gran
’" ast
Direct currency
NRBC
WBCN2,)
Fluorescence
Ret
I.
o
Fluorescence
PIt-O
Fluorescence
Figure 1. Scattergrams obtained with the XE-2100.
depending on fluorescence intensity, and the immature
reticulocyte fraction can be calculated and is shown on a
report. As a result, six scattergrams and two size distri-
bution curves are obtained.
The XE-2100 was calibrated before this evaluation and
checked with a quality control material daily prior to
experiments.
Reproducibility
Samples from healthy adults (n 5) were assayed five
times, and the coefficients of variation (CV) for each
parameter were calculated. Normal samples had no
NRBC, so the same number of samples with NRBC%
more than 0% were selected for evaluation of reprodu-
cibility ofNRBC determinations.
Carryover test
Triplicate measurements of a high-count (al-a3) sample
followed by a low-count (b l-b3) sample were performed,
and carryover effect was determined [2].
Stability during storage
Samples from healthy adults (n 3) were stored for up to
48h, and the changes in obtained parameters during
storage were determined. Each sample was stored in two
tubes, one at 4C and one at room temperature (25 C),
and measured at 0, 0.5, 4, 8, 24 and 48h after blood
collection. The samples stored at 4C were left at room
temperature for 10min before measurements. The per-
centage changes in parameters were calculated for each
sample, with the value at 0 h set at 100%. Mean values of
results for three samples were plotted.
Comparability to other methods
The samples were processed on the XE-2100 and the
laboratory’s routine haematology analyser (SE-9000,
Sysmex). The findings obtained with the two instruments
were compared. For leukocyte differentials, manual
differential counts were also performed on May-
Grnwald-Giemsa-stained peripheral blood films pre-
pared by the wedge methods. Medical technologists with
more than 10 years of experience performed 100 cell
differential counts. For comparison of differential counts,
samples were selected to ensure similar percentages of
morphologically normal and abnormal samples. For
reticulocyte analysis, the findings obtained with the
automated haematology analyzer R-3000 (Sysmex) were
used for comparison.
Bone marrow analysis
Bone marrow aspirates (n 15) were obtained from the
posterior iliac crest. The volume of aspirates ranged from
0.5 to 1.0 ml, and each sample was anticoagulated with
ethylenediamine tetraacetic acid-2K. For manual count-
ing, a 1"50 dilution of the marrow with Ttrk’s diluting
fluid was performed in a Melangeur blood-diluting
pipette for white blood cells. Nucleated cells of these
diluted samples were manually determined using a Buker
Tfirk haemocytometer. Smears were prepared on glass
slides, and after May-Grtnwald-Giemsa staining, cells
were observed under a microscope (500 count). For assay
with the XE-2100, bone marrow aspirates were diluted
with physiological saline (five or 10 times), due to the
limited volume of aspirates obtained, and immediately
assayed.
Comparisons with manual differentials were conducted
for total nucleated cell count, myeloid cells and erythroid
cells. White blood cell counts obtained with the XE-2100
were corrected for dilution ratios. Myeloid cells detected
by the XE-2100 included neutrophils, eosinophils and
basophils, and the erythroid cells detected by the
XE-2100 were NRBCs. Subpopulation percentages ob-
tained with the XE-2100 were recalculated, by addtion
ofNRBC count to denominators.
Results
Reproducibility
The CVs for complete blood counts varied from 0.5 to
2.9% (table 1). On comparison of the impedance and
optical methods for red blood cell count and platelet
count determinations, the CVs obtained by optical
methods were slightly higher than those obtained by
the impedance method. For leukocyte differential per-
centages, the CVs ranged from 1.2% for neutrophils to
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Table 1. Reproducibility test.
Mean
(range)
CV
(range)
WBC
RBC
RBC-o
Hgb
Hct
MCV
MCH
MCHC
Pit
Plt-o
RDW-SD
RDW-CV
PDW
MPV
P-LCR
PCT
Neu%
Lym%
Mon%
Eos%
Bas%
NRBC%
52.1 + 4.5 (x 102/.1) 1.3 + 0.5 (%)
(47.4-59.2) (0.6-1.9)
415.3+28.5(x104/.1) 0.5+0.2(%
(386.4-455.0) (0.2-0.6)
419.64-26.1 (x104/.1) 1.1 4-0.4(%
(397.6-460.2) (0.5-1.5)
14.2 4- 1.6 (g/dl) 0.5 4- 0.1 (%)
(13.0-17.0) (0.4-0.7)
36.6 4- 3.5 (o/0) 0.9 4- 0.2 (o/0)
(34.0-42.7) (0.7-1.2)
88.1 4- 6.1 (fl) 0.8 4- 0.2 (%)
(79.3-93.9) (0.6-1.0)
34.0 4- 2.4 (pg) 0.7 4- 0.2 (%)
(31.6-37.3) (0.5-0.9)
38.6 4- 1.2 (g/dl) 1.1 4- 0.2 (%)
(37.4-39.9) (0.7-1.3)
24.7 4- 8.1 ( 104/.1) 1.9 4- 0.8 (%)
(17.9-38.1) (1.1-3.3)
20.7 4- 8.8( 104/.1) 2.2 4- 1.0 (%)
(13.6-35.4) (0.9-3.3)
44.5 4- 7.2 (fl) 0.8 4- 0.3 (0/0)
(37.5-56.5) (0.3-1.1)
13.7 4- 1.5 (%) 0.5 4- 0.1 (o/0)
(12.8-16.4) (0.4-0.7)
11.6 4- 1.0 (fl) 2.3 4- 1.0 (%)
(9.9-12.6) (0.8-3.2)
10.2 4- 0.6 (fl) 0.9 4- 0.5 (o/0)
(9.1-10.7) (0.4-1.7)
26.8 4- 5.1 (0/0) 2.9 4- 1.0 (%)
(18.2-31.4) (1.9-4.1)
0.24-0.0(%) 2.34-0.4(/0)
(0.2-0.3) (1.8-3.0)
63.8 4- 4.1 (%) 1.2 4- 0.6 (%)
(58.9-69.1) (0.3-1.7)
22.5 4- 6.7 (o/0) 4.3 4- 1.4 (%)
(13.9-29.6) (2.3-5.9)
10.6 4- 3.6 (%) 6.0 4- 2.3 (%)
(5.5-15.7) (3.3-9.7)
2.1 + 1.5(%) 7.0+ 7.8(%
(9.6-4.7) (3.2-47.7)
1.0 4- 0.2 (%) 18.3 4- 12.7 (0/0)
(0.7-1.3) (4.3-34.9)
2.1 4- 0.8 (o/0) 9.4 4- 3.3 (o/0)
(1.3-3.3) (6.0-13.2)
18.3% for basophils. Samples used to evaluate NRBC
reproducibility had a mean NRBC% of 2.1% and a
mean CV of 9.4%.
Carryover
The mean values of high and low white blood cell counts
were 234.6 and 3.3 (xl03/gl); those for red blood cell
count were 614.0 and 203.7 (xl0a/gl); and those for
platelet count were 107.7 and 3.8 (x 104/gl).
Carryover for white blood cell count was 0%, while that
for red blood cell count was 0.24% and that for platelet
count was 0.67%.
Stability during storage at 4C and room temperature
Complete blood count parameters were stable for up to
8 h of storage regardless of temperature (figure 2). After
24h of storage, platelet count tended to decrease, espe-
cially at room temperature. Mean corpuscular volume
was increased after 24 h of storage at room temperature,
but not at 4C. The percentage changes up to 48 h were
within 10% for %neutrophils, %lymphocytes and
%monocytes at room temperature. The changes in
%basophils appeared to be high, but the actual changes
in percentages in differentials of basophils were at most
0.9% for 48h of storage at room temperatue. These
changes were smaller at 4C, and even at 48h after
blood collection, the percentage changes for %neutro-
phils and %lymphocytes were within 3%.
Comparability to other methods
The correlations for complete blood count parameters
(n 210) between the XE-2100 and SE-9000 analysers
are shown in table 2. Correlation coefficients ranged from
0.867 to 0.999. Leukocyte differential findings obtained
with the XE-2100, SE-9000 and manual method were
compared for 126 samples. The correlation coefficients
for %neutrophils, %lymphocytes, %monocyte and
%eosinophils were over 0.8 among these three methods
(figures 3-5). For %basophils, the r values among the
three methods were above 0.5, although the range of
variation for %basophils was narrow. Reticulocyte per-
centages obtained with the XE-2100 also correlated well
with those obtained with the R-3000 (figure 6). Samples
with more than 0 count NRBCs per 100 white blood cells
by either manual or XE-2100 methods were used for
comparison (n 77). The NRBC% obtained with the
XE-2100 correlated well with the manual count, with an
r of 0.859.
Quantitative analysis of bone marrow aspirates
The total nucleated cell count determined manually and
the corrected white blood cell count obtained with the
XE-2100 correlated well (figure 7). High correlations
were found between manual counting and XE-2100
determination tbr percentages of myeloid and erythroid
cells..
Discussion
The present evaluation showed that the accuracy of
determination of complete blood counts, leukocyte
differentials and reticulocyte percentages by the
XE-2100 were satisfactory. Although automated leuko-
cyte differential counting is now possible, it has remained
difficult to differentiate NRBCs from leukocytes, because
NRBCs are often distributed near lymphocytes on scat-
tergrams and discrimination of those two types of cells is
not easy. With the XE-2100, as a consequence of
treatment with lysing reagent and staining dye,
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Table 2. Correlations between XE-2100 and SE-9000for complete blood counts.
Equation
X SE-9000 Y XE-2100 y ax + b
mean+SD 91.54- 139.7 87.24- 141.3 WBC (10/lal) range (10.2-946.0) (10.0-973.9) y= 1.010x-5.307 0.999
mean 4- SD 345.2 4- 74.3 307.0 4- 64.0 RBC (104/lal) range (6.1-15.7) (6.2-15.5) y 0.858x + 10.803 0.996
mean 4- SD 10.4 4- 2.0 10.3 4- 2.0 Hgb (g/dl) range (171.0-552.0) (6.2-15.5) y 0.963x +0.209 0.995
mean 4- SD 31.9 4- 6.1 27.6 4- 5.2 Hct (%) range (18.0-47.0) (15.2-41.3) y 0.851x + 0.393 0.993
mean 4- SD 93.3 4- 7.9 90.4 4- 7.5 MCV (fl) range (64.8-121.1) (62.3-113.8) y 0.936x + 3.072 0.979
mean 4- SD 30.5 4- 3.2 33.7 4- 3.5 MCH (pg) range (17.7-41.9) (19.7-45.3) y 1.093x +0.318 0.990
mean 4- SD 32.7 4- 1.3 37.2 4- 1.7 MCHC (g/dl) range (27.3-36.1) (31.6-42.0) y 1.096x + 1.402 0.867
mean 4- SD 23.5 4- 16.2 22.9 4- 15.2 Pit (104/lal) range (1.4-94.3) (1.5-84.7) y 0.932x- 1.012 0.995
n-- 205.
leukocytes, NRBCs and erythrocytes have different sizes
and fluorescence intensities, and cell clusters distribute to
different areas on scattergrams and are therefore easy to
discriminate. Quantitative data on NRBCs can thus be
obtained. The precision ofNRBC determination with the
XE-2100 was excellent, and similar to that for the same
percentages of other leukocyte subpopulations. It is
advantageous for routine laboratories to be able to obtain
such precise measurement for NRBCs, as slight changes
in NRBC counts in patients can therefore be followed.
The accuracy of the XE-2100 was satisfactory at NRBC
counts of less than 10% obtained by the manual 100 eye
count method (n-- 74); no case was out of the range of
Rtimke’s 95% confidence limit [3]. Only the three cases
with the highest NRBC count were outside the 95%
confidence range, and all three were cases of leukaemia
(L2 and two cases of myelodysplastic syndrome), in
which the presence of abnormal cells may have been
the cause of the discrepancy between XE-2100 and
manual counts. The NRBC scattergram clearly revealed
the presence of NRBCs, as illustrated in figure 8. This
was a case ofsickle cell anaemia, and the scattergram also
shows an abnormally long area of distribution of ery-
throcyte ghosts. Laharrague et al. [4] reported that
NRBC
Manual count 9.0
XE-2100 1 0.5
NRBC : :
Incomplete lysis
of RBCs
Figure 8. NRBC scattergram for a case of sickle cell anaemia.
peculiar patterns of areas of eryhtrocyte ghosts were
frequently found for haemoglobinopathies and cases of
severe hepatic dysfunction using the Sysmex NE-8000,
and noted that the abnormal scattergrams obtained were
due to incomplete lysis of erythrocytes. The unusual
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scattergram in figure 8 may also have resulted in part
from the incomplete lysis of erythrocytes, and the NRBC
scattergram should be useful in revealing such abnorm-
alities. It should also be noted that enumeration of
NRBC does not provide just one additional parameter
for specimens--it also makes possible more accurate
leukocyte counting uninfluenced by the presence of
NRBCs, which may or may not have been included in
leukocyte counts by previous instruments.
Another recently developed haematology analyser, the
Cell Dyn 4000, which can also count NRBCs, has been
used for automated bone marrow analysis [5, 6]. The
degree of comparability with manual differentials of the
two instruments did not differ much, and both instru-
ments tended to underestimate erythroid cell counts. For
both instruments, the reagents used for assay and the
algorithm for differential counts are now designed for
analysis of peripheral blood, and there is room for
improvement of bone marrow analysis. However, it is
advantageous to laboratories to rapidly obtain numerical
data on bone marrow aspirates by precise and objective
methods. Because the CVs of subpopulation percentages
in bone marrow aspirates (data not shown) were similar
to those for peripheral blood, precise analysis was assured
for automated bone marrow analysis.
Although platelet counts can now be obtained with
sufficient reliability with conventional automated hae-
matology analysers, automated methods are not without
limitations. Results for a few abnormal cases must be
confirmed by methods not based on the impedance
principle, as the automated method cannot differentiate
platelets from small erythrocytes, erythrocyte fragments
or immune complexes [7]. With the impedance method,
only the size of cells can be detected, but with the optical
method, more accurate determination has become poss-
ible, with discrimination of platelets from other small
particles with similar sizes. Interference with large plate-
lets and platelet aggregation is also reduced. In our
evaluation, the optical method yielded platelet counts
as precisely as the conventional impedance method. We
did not encounter cases for which significantly inconsis-
tent platelet counts were obtained by the two methods.
With correct detection of platelets, routine laboratories
can reduce the time needed to perform the tedious and
time-consuming manual observations that are now some-
times required.
What can be emphasized as an advantage of XE-2100 is
the possibility of stable measurement over an extended
period of time. Leukocytes degenerate during storage and
thresholds on scattergrams correspondingly became
vague, but the XE-2100 could nevertheless differentiate
each subpopulation of cells. In order to obtain correct
differential counts with automated haematology analy-
sers, storage for only 8 h, and at longest 24 h, is generally
recommended. However, the XE-2100 provided stable
results over 48 h of storage, and is in this respect superior
to other haematology analysers presently available [1, 8].
The quality of measurements with it is not reduced by
storage for long periods of time; this should be of import-
ance to laboratories treating large numbers of samples.
The XE-2100 can assay 150 samples/h for complete
blood counts and leukocyte differentials, and 113
samples/h with the addition of reticulocyte analysis.
This throughput is higher than that ofany other analyser
presently on the market, and will help to shorten turn-
around times. The display and computer components of
the XE-2100 are Windows-based, and are therefore very
easy to operate even for individuals unfamiliar with the
instrument. Sophisticated data-processing and internet
communication network data-transmission protocols are
installed in the analyser. Communication, looking at the
same display, is possible among individuals working at
long distances.
There are financial issues laboratories must face, and the
above advantages should potentially permit savings in
the form of less stat and duplicate testing, and more
efficient use of clinician time. Clinically, the XE-2100
should make possible advanced detection of immature
cells. The immature cell information channel, the so-
called IMI channel, installed in the XE-2100 is now
used to detect haematopoietic progenitor cells [9], and
quantitative evaluation of immature granulocytes may
be possible in the near future.
In conclusion, the XE-2100 analyser will improve clinical
laboratory productivity and efficiency, and the more
detailed automated examination it enables will improve
both the quality and quantity of laboratory testing.
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